Ligand In-Person Investor Day: Updates on Ligand’s Strategy, Portfolio, and Financial Outlook
About The Event
Join the Ligand Pharmaceuticals Annual Investor Day in-person or via webcast, discussing Ligand‘s strategy, portfolio, and financial outlook supporting the clinical development of high-value medicines. Ligand’s growth strategy is focused on Project Finance, Royalty Monetization, M&A, and Technology Platforms.
The management team will provide updates on Ligand‘s portfolio of biotech and pharmaceutical assets, as well as review recent financial performance and its leading technology platforms. The event will also focus on the company’s growth drivers and multi-year financial guidance as well as providing detailed expectations for growth in 2024.
Ligand’s business model generates value for stockholders by creating a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand aims to offer investors an opportunity to participate in the promise of the biotech industry upside through a profitable and diversified business. A live question and answer session will follow the formal presentation.